Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 27, Number 2—February 2021
Research

Hepatitis C Virus Transmission Clusters in Public Health and Correctional Settings, Wisconsin, USA, 2016–20171

Karli R. Hochstatter2Comments to Author , Damien C. Tully2, Karen A. Power, Ruth Koepke, Wajiha Z. Akhtar, Audrey F. Prieve, Thomas Whyte, David J. Bean, David W. Seal, Todd M. Allen3, and Ryan P. Westergaard3
Author affiliations: University, New York, New York, USA (K.R. Hochstatter); University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA (K.R. Hochstatter, R. Koepke, W.Z. Akhtar, R.P. Westergaard); London School of Hygiene and Tropical Medicine, London, UK (D.C. Tully); Ragon Institute of MGH, MIT and Harvard, Cambridge, Massachusetts, USA (D.C. Tully, K.A. Power, D.J. Bean, T.M. Allen); Wisconsin Department of Health Services, Madison (R. Koepke, R.P. Westergaard); Wisconsin State Laboratory of Hygiene, Madison (A.F. Prieve, T. Whyte); Tulane University School of Public Health and Tropical Medicine, New Orleans, Louisiana, USA (D.W. Seal)

Main Article

Table 1

Demographics and risk factor information, by type of testing facility, for all 379 persons tested for HCV while in public health or correctional settings, Wisconsin, USA, 2016–2017*

Variable Overall no. (%) Setting of first HCV-positive test result, no. (%)
Syringe services program Corrections setting Local health department Other
Total
 379 (100)
 119 (31.4)
 154(40. 6)
 38 (10.0)
 68 (17.9)
Year first reported to WEDSS
2016 222 (58.6) 68 (57.1) 87 (56.5) 22 (57.9) 45 (66.2)
2017
 157 (41.4)
 51 (42.9)
 67 (43.5)
 16 (42.1)
 23 (33.8)
Age, y
18–29 190 (50.1) 57 (47.9) 77 (50.0) 19 (50.0) 37 (54.4)
30–39 154 (40.6) 39 (32.8) 75 (48.7) 16 (42.1) 24 (35.3)
>40
 35 (9.2)
 23 (19.3)
 2 (1.3)
 3 (7.9)
 7 (10.3)
Race/ethnicity
Non-Hispanic white 318 (83.9) 103 (86.6) 127 (82.5) 34 (89.5) 54 (79.4)
Hispanic or Latino 18 (4.8) 4 (3.4) 7 (4.6) 2 (5.3) 5 (7.4)
American Indian or Alaska Native 21 (5.5) 7 (5.9) 9 (5.8) 1 (2.6) 4 (5.9)
Asian 2 (0.5) 0 1 (0.7) 0 1 (1.5)
Non-Hispanic black or African American 12 (3.2) 4 (3.4) 5 (3.3) 1 (2.6) 2 (2.9)
Other/unknown
 8 (2.1)
 1 (0.8)
 5 (3.3)
 0
 2 (2.9)
Sex
F 93 (24.5) 44 (36.9) 14 (9.1) 13 (34.2) 22 (32.3)
M
 286 (75.5)
 75 (63.0)
 14 (90.9)
 25 (65.8)
 46 (67.7)
Ever injected drugs
Yes 177 (46.7) 98 (82.4) 16 (10.4) 32 (84.2) 31 (45.6)
No or unknown
 202 (53.3)
 21 (17.7)
 138 (89.6)
 6 (15.8)
 37 (54.4)
Ever shared works
Yes 145 (38.3) 88 (74.0) 10 (6.5) 29 (76.3) 18 (26.5)
No, unknown, or NA
 234 (61.7)
 31 (26.1)
 144 (93.5)
 9 (23.7)
 50 (73.5)
MSM
Yes 8 (2.1) 4 (3.4) 0 2 (5.3) 2 (2.9)
No or unknown
 371 (97.9)
 115 (96.6)
 154 (100)
 36 (94.7)
 66 (97.1)
Ever incarcerated
Yes 335 (88.4) 92 (77.3) 154 (100) 34 (89.5) 54 (79.7)
No or unknown 44 (11.6) 27 (22.7) 0 4 (10.5) 14 (20.6)

*HCV, hepatitis C virus; MSM, men who have sex with men; NA, not applicable; WEDSS, Wisconsin Electronic Disease Surveillance System.

Main Article

1The methods described in this article, along with preliminary results from the first 231 specimens analyzed, were presented in poster format at the 8th International Conference on Hepatitis Care in Substance Users; 2019 Sep 11–13; Montreal, Quebec, Canada.

2These first authors contributed equally to this article.

3These senior authors contributed equally to this article.

Page created: December 07, 2020
Page updated: January 23, 2021
Page reviewed: January 23, 2021
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external